Surgery Partners, Inc. (SGRY) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The company reported strong financial performance with a 12% revenue increase and a 25% net income growth. Despite risks mentioned in forward-looking statements, the absence of negative details in the Q&A suggests no major concerns from analysts. The market cap indicates a moderate reaction, leading to a positive stock price movement prediction.
Key Financial Performance
Revenue $720 million, representing a 12% increase year-over-year, driven by higher surgical case volumes and improved payer mix.
Adjusted EBITDA $120 million, up 15% year-over-year, attributed to operational efficiencies and cost management initiatives.
Net Income $25 million, a 25% increase year-over-year, due to revenue growth and effective expense control.
Operating Cash Flow $85 million, a 10% increase year-over-year, supported by improved collections and working capital management.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-looking statements risk: There are risk factors that could cause future results to be materially different from these statements as described in this morning's press release and the reports we file with the SEC.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Benjamin Mayo
Brian Tanquilut
COO National
Cantor Fitzgerald
Co Research
Conference reminder
Cowen Research
Director Executive
Division Albert
Division Benchmark
Division Benjamin
Division Cantor
Division EDT
Division Gillmor
Division Spivack
Division Walsh
EDT Ladies
Fitzgerald Co
Gillmor KeyBanc
Group President
Joanna Gajuk
LLC Research
National Group
Officer Chief
Officer statement
Partners Chief
Partners Conference
President Brian
President COO
Research Division
SEC duty
Walsh Barclays
gentleman greeting
SGRY Transcript
Surgery Partners, Inc. (SGRY) Q1 2026 Earnings Call Transcript
Positive5-5
The company reported strong financial performance with a 12% revenue increase and a 25% net income growth. Despite risks mentioned in forward-looking statements, the absence of negative details in the Q&A suggests no major concerns from analysts. The market cap indicates a moderate reaction, leading to a positive stock price movement prediction.
Surgery Partners, Inc. (SGRY) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Neutral3-10
Surgery Partners, Inc. (SGRY) Presents at Barclays 28th Annual Global Healthcare Conference Prepared Remarks Transcript
Neutral3-10
Surgery Partners, Inc. (SGRY) Q4 2025 Earnings Call Transcript
Unknown3-3
The earnings call presents a mixed picture. Positive elements include strategic M&A plans, new facility investments, and a share buyback program, indicating confidence. However, challenges such as payer mix issues, slow revenue growth, and cautious guidance offset these positives. The Q&A reveals management's plans to address these challenges, but uncertainty remains. Given the company's market cap and the balance of positive and negative factors, the stock price is likely to remain stable in the short term, resulting in a neutral rating.
SGRY Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
